Board of Directors

Top leaders from academia, government, and industry, representing a variety of biotech disciplines, serve on Bio Nebraska’s Board of Directors.

Current Directors

Josh Johnson, Chairman

Director of Biologics Operations, Huvepharma

Michael Dixon, Ph.D.

President and CEO, UNeMed Corporation

Rachel Hurley

Midwest Government Affairs Manager, Bayer Crop Science

Matthew Kreifels

Vice President of Sales, Streck Inc.

Tyler Martin, M.D.

CEO, Adjuvance Technologies

Kyle Nixon

Director of Supply Chain for the Americas, Novozymes

Todd Sneller

Sneller Associates

Charles Bicak, Ph.D.

Senior Vice Chancellor, University of Nebraska at Kearney 

Ronnie Green, Ph.D.

Chancellor, University of Nebraska-Lincoln

Christopher Kratochvil, M.D.

Associate Vice Chancellor, University of Nebraska Medical Center

Gary Madsen, Ph.D.

CEO, ProTransit Nanotherapy

Lyle Middendorf

Sr. VP and Chief Technical Officer, LI-COR Biosciences

Laurie Reagan

Plant Manager, BD
*Beginning in 2021

Amy Thompson

Director of Business Development, McCarthy Building Companies
*Beginning in 2021



Executive Leadership

Rob Owen

Executive Director

Sasha Forsen

Assistant Director